Table: Towa Pharmaceutical -Q1 group results

TOWA PHARMACEUTICAL

08/08/2016 07:00

Aug 8 (Reuters)-  
             Towa Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Jun 30, 2016        Jun 30, 2015     Mar 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             20.18               19.43            93.50     
                 (+3.8 pct)          (+17.9 pct)      (+13.9 pct)  
  Operating          1.34                3.01            10.50     
                 (-55.6 pct)         (+43.5 pct)      (-5.7 pct)   
  Recurring     loss 672 mln             3.34            10.35     
                                     (+65.2 pct)      (+1.9 pct)   
  Net             loss 1.10              2.24             7.45     
                                     (+74.6 pct)      (-3.1 pct)   
  EPS          loss 67.02 yen        131.82 yen       454.18 yen   
  Ann Div                             95.00 yen        95.00 yen   
  -Q2 div                             47.50 yen        47.50 yen   
  -Q4 div                             47.50 yen        47.50 yen   
   
  NOTE - Towa Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T  
  ((Tokyo Headline News Desk +813 6441 1812))